A staff education module on how dialysis dose is measured, what the landmark adequacy trials from NCDS to HEMO actually showed, and why good care means more than hitting a Kt/V number.
Developed by Craig G. Hurwitz, MD
Dialysis Adequacy · Staff Education
Nephrology spent 50 years trying to answer this question.
Move the dose slider and watch what decades of research taught us.
The surprising answer
The steep win is climbing out of underdialysis. Past the target zone, benefit flattens while burden keeps climbing. So the real question was never how high can we push one number.
Illustrative. The curves are schematic of the evidence pattern, not plotted trial data. Marker positions are approximate. Sources explored in the sections that follow.
The Story So Far
Adequacy did not start as a number. It started as a question about who was dying and why. Drag through the years, or tap a milestone, to see what happened, why it mattered, and how it changed practice.
The Anatomy of a Number
Kt/V tells us how much urea clearance is delivered during a dialysis treatment. Move each slider to see how the three parts behave and combine.
K = Dialyzer Clearance
How well the dialyzer clears, or completely removes, urea from the blood.
Measured in mL/min. At K = 250 mL/min, the dialyzer clears the urea from that many mL of blood every minute.
t = Time on Dialysis
How long the dialyzer has time to work during the treatment.
Measured in minutes. The longer the treatment, the more urea can be cleared. Now: 4 h 0 min.
V = Volume of Distribution
The size of the body water space where urea is distributed.
Measured in liters. The larger the body water volume, the more urea must be cleared to reach the same Kt/V.
How K, t, and V work together
Single-pool Kt/V
What does Kt/V mean?
Kt/V is the number of body-water volumes worth of urea clearance the treatment delivered.
Cleared is not the same as emptied. Clearance recirculates the same water, so one volume cleared (Kt/V 1.0) removes about 63 percent of urea, not all of it. The water space is never drained.
A Kt/V of 1.4 means the treatment delivered clearance equal to 1.4 times the patient's entire urea distribution volume. A higher K, a longer t, or a smaller V all raise Kt/V. All three matter.
Illustrative animation. spKt/V is the genuine K×t/V ratio. KDOQI target spKt/V is 1.4, minimum 1.2 (thrice weekly). The urea-removed figure uses the idealized single-pool URR = 1 minus e to the power of negative Kt/V, ignoring fluid removal and rebound. Source: Gotch and Sargent, Kidney Int 1985; KDOQI, AJKD 2015.
The Variable People Forget
Here is the lesson no paragraph teaches as well as a picture. Two patients get the exact same dialyzer for the exact same time. Only the body water differs. Watch the delivered dose split apart.
Shared prescription, identical for both patients
Both get the same 60.0 L of blood-equivalent cleared (K × t).
Patient A
Smaller body, 35 L water space
Patient B
Larger body, 55 L water space
Delivered dose is measured right at the end of the run. Minutes later, urea seeps back out of tissues into the blood, so the equilibrated Kt/V is lower than the single-pool number.
The next section follows that rebound through the body compartments and shows why eKt/V, not spKt/V, is what the patient actually received.
Illustrative. spKt/V is the genuine K×t/V ratio. eKt/V uses the Daugirdas rate equation, eKt/V = spKt/V minus 0.6 times (spKt/V divided by hours) plus 0.03, for arteriovenous access. Source: Daugirdas, JASN 1993; Tattersall, NDT 1996.
Measuring the Real Dose
The dialyzer's spec sheet predicts a dose. What the patient actually received is not read off a chart, it is back-calculated from two blood draws using the Daugirdas equation. Move the measured values and watch the delivered number form.
K × t / V from the dialyzer's catalog clearance. A flow-condition estimate made before the run.
Calculated after the run from pre and post BUN, time, and weight loss. It captures the true effective clearance, recirculation, and fluid removal.
Measured at the chair
Post-dialysis BUN must be lower than pre-dialysis BUN.
The Daugirdas second-generation equation
URR alone misses two things: urea is still being generated during the run, and pulling off fluid carries urea out by convection. The equation corrects for both.
Delivered single-pool Kt/V
The single biggest error is how the post sample is taken. Drawn at full blood flow, access and cardiopulmonary recirculation dilute it, the post-BUN reads falsely low, and the delivered Kt/V looks falsely high.
Use the slow-flow method: drop the blood pump to about 100 mL/min for 15 seconds, then draw from the arterial line. A clean post-BUN is what makes every number above trustworthy.
spKt/V here is the genuine Daugirdas second-generation estimate from the values entered, not an illustration. The equilibrated eKt/V, which accounts for post-dialysis rebound, is lower still and is covered in the next section. Source: Daugirdas JT, JASN 1993; KDOQI Hemodialysis Adequacy, AJKD 2015.
Where The Targets Came From
The 1981 NCDS used a 2 by 2 design: two treatment times crossed with two levels of urea exposure. Set each arm and see the direction the trial reported.
Time-averaged urea (BUN exposure)
The factor that mattered most in NCDS
Treatment time
The borderline factor (p = 0.06)
Source: Momciu B, Chan CT. Semin Dial 2020; Himmelfarb J, Ikizler TA. NEJM 2010.
One Number, Two Pools
Urea does not leave the body from one tidy tank. Run a session and watch what happens after the machine stops.
Calculated from the immediate post-dialysis BUN. It assumes urea sits in one evenly mixed compartment, so it reads the lowest point, right when the machine stops.
Uses a BUN drawn about 30 to 60 minutes later, after urea from inside cells redistributes and rebounds. Because the true post value is higher, eKt/V runs lower than spKt/V, typically by roughly 0.2.
Illustrative animation of urea kinetics. Rebound occurs because intravascular and interstitial urea clear quickly while intracellular urea equilibrates slowly. eKt/V is more physiologic, but the 2015 KDOQI guideline notes that evidence justifying a preference for eKt/V over spKt/V is lacking. Source: Momciu B, Chan CT. Semin Dial 2020; KDOQI, AJKD 2015.
The Ceiling
In 2002, the HEMO Study put the more-is-better assumption to a randomized test in 1,846 patients. Make your call before you see the result.
If you raise the dose from a standard to a high target, what happens to mortality?
No mortality benefit.
Over up to 7 years, the high-dose arm showed no significant survival advantage, and the same held for seven other prespecified outcomes and for high versus low flux.
All-cause mortality, high dose vs standard dose
Seven other prespecified outcomes: none reached significance. Every confidence interval crossed the line of no effect.
A later analysis found that pushing Kt/V higher did little to lower many non-urea uremic solutes. If those solutes drive outcomes, then clearing urea harder does not move the needle. Urea was a convenient marker, not the whole problem.
Original NNH recreation of the published effect size, not the journal figure. Source: Eknoyan G et al. NEJM 2002; Meyer TW et al. JASN 2016.
One Thing Well
Here is a patient hitting target: Kt/V 1.5. Now switch on what else might be true about them. Watch the number that does not move.
This same patient also has...
Kt/V measures one thing well. It does not measure everything that matters.
Why one marker is not enough: how well hemodialysis clears each solute class
Kt/V indexes urea only. As Meyer and colleagues argued, an index based on urea alone does not provide a sufficient measure of dialysis adequacy. Illustrative comparison of solute classes. Source: Meyer TW et al. JASN 2016; Jones CB, Bargman JM. Semin Dial 2018.
The Hidden Superpower
Dialysis clears in three sharp rescues a week. A native kidney clears every hour of every day. Set how much kidney is left and watch a week of toxin buildup respond.
around the clock, on top of dialysis
Standardized weekly Kt/V (stdKt/V) counts both the machine and the kidney, the math that makes less-frequent schedules defensible.
The kidney never clocks off
The machine works about 12 hours a week. A working kidney works all 168.
A dialysis patient with a Kru of 4 mL/min still has real, continuous native clearance. Residual function is not a rounding error, it is 168 hours a week of work the machine cannot match.
The survival and quality-of-life links are associations from observational cohorts, not proof of cause. The fluid and solute control follows directly from continuous clearance.
Illustrative simulation. Toxin level is relative and unitless, modeling continuous generation against intermittent dialysis and continuous residual clearance. Weekly clearance volume is Kru times the minutes in a week. Source: Shafi T et al. CJASN 2010; Obi Y et al. AJKD 2016; KDOQI Hemodialysis Adequacy, AJKD 2015.
When Less Can Be Enough
If the native kidney still does real work, the machine may not need to do all of it. Set the schedule and the residual clearance, and watch where weekly adequacy lands.
Dialysis schedule
Residual urea clearance (Kru)
Roughly 1 to 1.5 L of urine per day
Solid bar is total weekly stdKt/V. The dashed marker shows how much the machine alone contributes.
Why this is not forever
Residual kidney function tends to fade over months. The incremental approach is a starting prescription, not a fixed one. Re-measure Kru on a schedule, and step up frequency before the total slips below target.
In a large incident cohort, patients starting twice weekly tended to preserve residual kidney function longer. Reported as an association, not a proven survival benefit.
Systematic review found twice weekly feasible in selected patients with meaningful residual function, with careful monitoring as the recurring caveat.
A consensus framework outlines candidate selection and the schedule for re-checking residual function, to escalate before adequacy is lost.
Illustrative. Target band reflects KDOQI non-thrice-weekly stdKt/V goal of about 2.3 with a minimum near 2.1. Source: KDOQI, AJKD 2015; Obi Y et al. AJKD 2016; Fan WF et al. 2017; Murea M et al. consensus 2025.
The Bigger Picture
Kt/V is one spoke. A patient does well when the whole wheel turns. Tap any spoke to see what it carries, and why no single number stands in for the rest.
Each spoke is something a patient feels or a risk they carry. Kt/V sits among them as one well-validated, easily measured spoke, not the hub. Tap a spoke to explore it.
Use Tab and Enter to move through the spokes.
Kt/V remains important. But adequacy is bigger than Kt/V.
Fifty years of trials taught the field that a single dose number, pushed higher, did not keep making patients better. What kept mattering was everything the number did not capture: volume, residual function, nutrition, symptoms, time spent recovering, and the patient's own sense of a livable life.
We do not chase a number. We optimize the patient.Reference list summarizes the practice history presented across this module. Full citations available on request.
